A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 21 Mar 2018
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Endometrial cancer; Glandular and epithelial neoplasms
- Focus Adverse reactions
- 15 Mar 2018 Status changed from recruiting to active, no longer recruiting.
- 19 Aug 2016 Status changed from not yet recruiting to recruiting.
- 25 Apr 2016 New trial record